Regeneración ósea, terapia celular e ingeniería tisular

Medicina Clinica

Volumn 116, Issue 1, 2001, Pages 23-34

  Becerra, José ^a,b   Andrades, José Antonio ^a   Santamaría, Jesús A ^a   Cifuentes, Manuel ^b   Guerado, Enrique ^a  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOMEDICAL ENGINEERING; BONE DEVELOPMENT; BONE REGENERATION; CULTURE TECHNIQUE; CYTOLOGY; GENE THERAPY; HUMAN; OSTEOBLAST; REVIEW; STEM CELL;

ANIMALS; BIOMEDICAL ENGINEERING; BONE REGENERATION; CULTURE TECHNIQUES; GENE THERAPY; HUMANS; OSTEOBLASTS; OSTEOGENESIS; STEM CELLS;

EID: 0035852555     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71706-X     Document Type: Review

References (89)

1. Stocum DL. Limb regeneration: re-entering the cell cycle. Curr Biol 1999; 9: 644-646.
2. Stocum DL. New Tissues from Old, Science 1997, 276: 15.
3. Brockes JP. Amphibian Limb Regeneration: Rebuilding a Complex Structure. Science 1997; 276: 81-87.
4. Stein GS, Lian JB. Molecular mechanisms mediating development and hormoneregulated expression of genes in osteoblasts: An integrate relationship of cell growth and differentiation. En: Noda M, editor. Cellular and molecular biology of bone. San Diego: Academic Press; 1993: 47-95.
5. Hinchliffe J, Johnson D. The development of the Vertebrate Limb. Nueva York: Oxford Press, 1980.
6. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988; 242: 1528-1534.
7. Einhorn TA. The Cell and Molecular Biology of Fracture Healing. Clin Orthop Relat R 1998; 355 (Supl): 7-21.
8. Marsh D. Concepts of Fracture Union, Delayed Union, and Nonunion. Clin Orthop Relat R 1998; 355 (Supl): 22-30.
9. Byers P, Bonardio J. The molecular basis of clinica heterogeneity of osteogenesis imperfecta: mutations in type I collagen genes have different effects on collagen processing. En: Lloyd J, Scriver C, editores. Genetic and metabolic diseases in pediatrics. Londres: Butterworth, 1985; 56-90.
10. Haynesworth SE, Goldberg VM, Caplan AI. Diminution of the number of mesenchymal stem cells as a cause for skeletal aging. En: Buckwalter JA, Goldberg VM, Woo SLV, editores. Musculoskeletal soft-tissue aging: impact on mobility. Section 1, Chapter 7. Rosemont: AAOS, 1994; 80-86.
11. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998; 16: 155-162.
12. Connolly JF. Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin Orthop Relat R 1998; 355 (Supl): 257-266.
13. Andrades JA, Nimni ME, Santamaria JA, Becerra J. Bone Marrow cells induced in vitro by a modified human TGF-β1 form cartilage and bone when they are implanted in vivo. Bone. En prensa.
14. Lane JM. Biologic Enhancement of Fracture Repair. Clin Orthop Relat R 1998; 355 (Supl): 359-360.
15. Rosier RN. Regional Gene Therapy. Clin Orthop Relat R 1998; 355 (Supl): 361-363.
16. Caplan AI, Bruder SP. Cell and molecular engineering of bone regneration. En: Lanza R, Langer R, Chick W, editores. Textbook of tissue engineering. Georgetown: RG Landes Company, 1997; 603-618.
17. Owen M. Linage of osteogenic cells and their relationshio to the stromal system. En: Peck WA, editor. Bone and mineral research. Amsterdam: Elsevier, 1985; 3: 1-25.
18. Caplan AI Mesenchymal stem cells. J Orthop Res 1991; 9: 641-650.
19. Broudy V, Zuckerman S, Jemalani S, Fitchen J, Bagby G. Monocytes stimulates fibroblastoid bone marrow stromal cells to produce multilineage hematopoietic growth factors. Blood 1986; 68: 530-534.
20. Triffitt J. lniciation and enhancement of bone formation: a review. Acta Orthop Scand 1987; 58: 673-684.
21. Caplan Al The mesengenic process. Clin Plast Surg 1994; 21: 429-435.
22. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
23. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD et al. Culture adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857-4861.
24. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI et al. Mesenchymal cell-based repair of large full-thickness defects of articular cartilage. J Bone Joint Surg 1994; 76: 579-592.
25. Manologas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesys and treatment of osteoporosis. Endocrin Rev 2000; 21: 115-137.
26. Nimni ME. Polypeptide growth factors: targeted delivery sistems. En: Elsevier. Biomaterials 1997; 18: 1201-1225.
27. Reddi AJ. BMPs: Actions in flesh and bone. Nat Med 1997; 3: 837-839.
28. Trippel SB. Potential role of insulinlike growth factors in fracture healing. Clin Orthop Relat R 1998; 355 (Supl): 301-313.
29. Trippel SB. Bone formation and repair. En: Brighton CT, Friedlaender G, Lane JM, editores. Biologic regulation of bone growth. Rosemont, IL. Am Acad Orthop Surg 1994; 39-60.
30. Balk SD, Whitfield JF, Youdale T, Brown AC. Roles of calcium, serum, plasma and folic acid in the control of proliferation of normal and rouse sarcoma-virus infected chicken fibroblasts. Proc Natl Acad Sci USA 1973; 70: 675-679.
31. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of external smooth muscle cells in vitro. Proc Nat Acad Sci USA 1974; 71: 1207-1210.
32. Yarden Y, Ulrich A. Growth factor receptor tyrosine kinases. Ann Rev Biochem 1988; 57: 443-478.
33. McGill JJ, Strates BS, McGuire MH. Stimulation of osteogenesis by PDGF and TGF adsorbed on microcrystals of hydroxiapatite. J Bone Min Res 1990; 6 (Supl 1): 503.
34. McCarthy TL, Centrella M, Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 1989; 125: 2118-2126
35. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. Cell Biol 1989; 109: 1-6.
36. Radomsky ML, Thompson AY, Spiro RC, Poser JW. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop 1998; 355 (Supl): 283-293.
37. Nagai H, Tsukuda R, Mayahara H. Effects of basic fibroblast growth factor on bone formation in growing rats. Bone 1995; 16: 367-373.
38. Sasaki T, Watanabe C. Stimulation of osteoinduction in bone wound healing by high molecular hyaluronic acid. Bone 11995; 16: 9-15.
39. Kingsley DM. The transforming growth factor beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-146.
40. Bostrom MPG, Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat R 1998; 355 (Supl): 124-131.
41. Oreffo RO, Bonewald L, Kukita A, Garrett IR, Seyedin SM, Rosen D et al. Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts. Endocrinology 1990; 126: 3069-3075.
42. Duneas N, Crooks J, Ripamonti U. Transforming growth factor-β1: induction of bone morphogenetic protein gene expression during endochondral bone formation in the baboon, and sinergystic interaction with osteogenic protein-1 (BMP-7). Growth factors 1998; 15: 259-277.
43. Rosier RN, O'Keefe RJ, Hicks DG. The potential role of transforming growth factor beta in fracture healing. Clin Orthop Relat R 1998; 355 (Supl): 294-300.
44. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-899.
45. Reddi AH. Initiation of fracture repair by bone morphogenetic proteints. Clin Orthop Relat R 1998; 355: 66-72.
46. Bostrom MPG. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop Relat R 1998; 355 (Supl): 116-123.
47. Yang U, Jin Y. Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions. Clin Orthop 1990; 257: 249-256.
48. Kawaguchi H, Kurokawa T, Hoshino Y, Kawahara H, Ogata E, Matsumoto T. Immunohistochemical demonstration of bone morphogenetic protein-2 and transforming growth factor-beta in the ossification of the posterior longitudinal ligament of the cervical spine. Spine 1992; 17: 33-36.
49. Bostrom MP, Lane JM, Berberian WS, Missri AA, Tomin E, Weiland A et al. Immunolocalization and expression of bone morphogenetic protein 2 and 4 in fracture healing. J Orthop Res 1995; 13: 357-367.
50. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T et al. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 1996; 327: 272-282.
51. Cook SD. Acceleration of bone healing with OP-1 in a canine noncritical size deffect model. Second Internacional OP-1 Conference. Boston, MA, 1997.
52. Bonn D. The application of cell biology to broken bones. Lancet 1999; 353: 650.
53. Second Internacional OP-1 Conference. Boston, MA, 1997.
54. International Conference on Bone Morphogenetic Proteins. Lake Tahoe, CA, 2000.
55. Cheal EJ, Mansmann KA, DiGioia AM III, Hayes WC, Perren SM. Role of intergragmentory strain in fracture healing of a healing osteotomy. J Orthop Res 1991; 9: 131-142.
56. Chiroff R, Weber J, White E. Tissue in growth of replamineform implants. J Biomed Mater Res 1975; 6: 29.
57. Frost H. A New direction for osteoporosis research: A review and proposal. Bone 1991; 12: 249-437.
58. Moore DC, Chapman MW, Manske D. The evaluation of a biphasic calcium phosphate ceramic for use in grafting long bone diaphyseal defects. J Orthop Res 1987; 5: 356-365.
59. De Groot R. Effect of porosity and fisicochemycal properties on the stability, resortion and strenght of calcium phosphate ceramics. Ann NY Acad Sci 1998; 523: 227-233.
60. Nimb L, Gotfredsen K, Jensen JS. Interface mechanics and histomorphometric analysis of different types of bioceramics in canine bone. Acta Orthop Scand 1992; 63: 28-32.
61. Chapman MW, Bucholz R, Cornell CN. Treatment of acute fractures with a collagen-calcium phosphate graft material: a randomized clinical trial. J Bone Joint Surg 1997; 79A: 495-502.
62. Hollinger JO, Battistone GC. Biodegradable bone repair materials: synthetic polymers and ceramics. Clin Orthop 986; 207: 290-305.
63. Laurencin CT, Lane JM. Poly (lactic acid) and poly (glicolic acid): orthopaedic surgery applications. En: Brighton Ct, Friedlaender G, Lane JM. editores. Bone formation and repair. Park Ridge, IL: American Academy of Orthopaedic Surgeons Symposium, 1994; 325-339.
64. Becerra J, Andrades JA, Ertl DC, Sorgente N, Nimni ME. Demineralized bone matrix mediates differentiation of bone marrow stromal cells in vitro: effect of age of cell donor. J Bone Min Res 1996; 11: 1703-1714.
65. Andrades JA, Han B, Becerra J, Sorgente N, Hall FL, Nimni ME. A recombinant human TGF-β1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. Exp Cell Res 1999; 250: 485-498.
66. Mardon HJ, Bee J, Von der Mark K, Owen ME. Development of osteogenic tissue in diffusion chambers from early precursors cells in bone marrow of adult rats. Cell Tissue Res 1987; 250: 157-165.
67. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988; 254: 317-330.
68. Herbertson A, Aubin JE. Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 1995; 10: 285-294.
69. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997; 21: 225-235.
70. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat R 1998; 355 (Supl): 247-256.
71. Lian JB, Gundberg CM. Osteocalcin: biochemical considerations and clinical applications. Clin Orthop 988; 226: 267-291.
72. Centrella M, McCarthy TL, Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 1987; 262: 2869-2874.
73. Robey PG, Young M, Flanders KC, Roche NS, Kondaiah P, Reddi AH et al. Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-beta) in vitro. J Cell Biol 1987; 105: 457-463.
74. Noda M. Transcriptional regulation os osteocalcin production by transforming growth factor-beta in raf osteoblast-like cells Endocrinology 1989; 124: 612-617.
75. Centrella M, McCarthy TL, Canalis E, Connecticut H. Transforming growth factor-beta and remodeling of bone. J Bone Joint Surg 1991; 73 (Supl A): 1418-1428.
76. Bonewald LF, Mundy R. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat R 1990; 250: 261-276.
77. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994; 161: 218-228.
78. Long MW, Robinson JA, Ashcraft EA, Mann KG. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 1995; 95: 881-887.
79. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992; 267: 20352-20362.
80. Bergman J, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ. Age-related changes in osteogenic stem cell in mice. J Bone Miner Res 1996; 11: 568-577.
81. Inoue K. Ohgushi H, Yoshikawa T, Okumura M, Sempuku T, Tamai S et al. The effect of aging on bone formation in porous nydroxyapatite: Biochemical and histological analysis. J Bone Miner Res 1997; 12: 989-994.
82. Quarto R, Thoma D, Liang T. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995; 56: 123-129.
83. Bruder SP, Ricalton NS, Boynton RE, Connolly FJ, Jaiswal N, Zaia J et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 1998; 13: 655-663.
84. Kadiyala S, Jaiswal N, Bruder SP. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Enf 1997; 3: 173-185.
85. Liebergall M, Young RG, Ozawa N. The effects of cellular manipulation and TGF-β in a composite bone graft. En: Brighton CT, Friedlaender GE, Lane JM, editores. Bone formation and repair. Chapter 26. Rosemont: AAOS, 1994; 367-377.
86. Si X, Jin Y, Yang L. Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. Int J Oral Maxillofac Surg 1998; 27: 310-314
87. Fujisawa R, Mizuno M, Nodasaka Y, Kuboki Y. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. En: Fischer G, editor. Verlag. Matrix Biology. 1997; 16: 21-28.
88. Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD et al. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop Relat R 1998; 355 (Supl): 148-153.
89. Goldstein SA, Bonadio J. Potential role for direct gene transfer in the enhancement of fracture healing. Clin Orthop Relat R 1998; 355: 154-162.